CROI 2016 Program at a Glance

Program and Agenda

593 Acute and Chronic Hepatitis E Virus Infection in HIV- Infected United States Women Mark H. Kuniholm 1 ; Edgar Ong 2 ; Boris M. Hogema 3 ; Marco Koppelman 3 ; Kathryn Anastos 1 ; Marion Peters 4 ; Eric C. Seaberg 5 ; Chloe Thio 6 ; Kenrad E. Nelson 5 ; Jeffrey Linnen 7 1 AlbertEinsteinCollofMed,Bronx,NY,USA; 2 Hologic, Inc.,SanDiego, CA,USA; 3 SanquinRsrandDiagnostics,Amsterdam,Netherlands; 4 Univ ofCaliforniaSanFrancisco,SanFrancisco,CA,USA; 5 JohnsHopkins BloombergSchofPH,Baltimore,MD,USA; 6 JohnsHopkinsUniv, Baltimore,MD,USA; 7 Hologic, Inc,SanDiego,CA,USA 594 High Prevalence of Anti-HEV IgG Is Not AssociatedWith HIV Infection in Rakai, Uganda Denali Boon 1 ; Andrew D. Redd 2 ; Oliver Laeyendecker 3 ; Ponsiano Ocama 4 ; Steven J. Reynolds 3 ; Ronald H. Gray 5 ; Robert H. Purcell 2 ; Thomas C. Quinn 6 ; Lara Stabinski 7 ; for the Rakai Health Sciences Program 1 JohnsHopkinsUniv,Baltimore,MD,USA; 2 NIAID,NIH,Bethesda,MD, USA; 3 NIH,Bethesda,MD,USA; 4 MakerereUnivCollofHlthScis,Kampala, Uganda; 5 JohnsHopkinsBloombergSchofPH,Baltimore,MD,USA; 6 JohnsHopkinsUnivSchofMed,Baltimore,MD,USA; 7 Officeof theUS GlobalAIDSCoordinator,USDeptofState,Washington,DC,USA 2:45 PM-4:00 PM Pathogenesis of HCV Infection: Activation and Exhaustion 595 Oxylipin Metabolites As Markers of Inflammation and Liver Disease in HCV Infection Session P-N10 Poster Abstracts Hall A/B Susanna Naggie 1 ; Eric G. Meissner 2 ; Lisa St. Johns-Williams 3 ;Will Thompson 3 ; Derek Cyr 3 ; Joseph Lucas 3 ; Arthur Moseley 3 ; Shyam Kottilil 4 ; Keyur Patel 5 1 DukeUnivSchofMed,Durham,NC,USA; 2 MedUnivofSouthCarolina, Charleston,SC,USA; 3 DukeUniv,Durham,NC,USA; 4 UnivofMaryland MedCntr,Baltimore,MD,USA; 5 DukeClinicalRsr Inst,Durham,NC,USA

599 Hepatic & Peripheral Responses to 2 Different DAA Regimens in HIV/HCV Coinfection Louisa C. Howard 1 ; Anita Kohli 2 ; Julia Purdy 1 ; Elana S. Rosenthal 1 ; Shikha Shrivastava 3 ; Bhawna Poonia 3 ; Henry Masur 1 ; Shyam Kottilil 4 ; Eleanor M.Wilson 5 1 NIH,Bethesda,MD,USA; 2 DignityHlth,St. Joseph’sHosp,Phoenix,AZ, USA; 3 The InstofHumanVirology,UnivofMaryland,Baltimore,MD, USA; 4 UnivofMarylandMedCntr,Baltimore,MD,USA; 5 InstofHuman Virology,Baltimore,MD,USA 600 Intrahepatic Immune Composition Changes Markedly With Interferon-Free HCV Treatment Cody Orr 1 ; Johannes Aartun 1 ; Henry Masur 2 ; Shyam Kottilil 3 ; Eric G. Meissner 1 1 MedUnivofSouthCarolina,Charleston,SC,USA; 2 NIH,Bethesda,MD, USA; 3 UnivofMarylandMedCntr,Baltimore,MD,USA 601 GWAS of Relapse in HIV-1/HCV Coinfected Patients TreatedWith LDV/SOF in ION-4 1 ColumbiaUniv,NewYork,NY,USA; 2 GileadScis, Inc,FosterCity,CA, USA; 3 JohnsHopkinsUniv,Baltimore,MD,USA; 4 DukeUnivSchofMed, Durham,NC,USA 602 Pacbio Sequencing of the HCV Envelope: From Early Acute to Chronic Infection Cynthia K. Ho 1 ; Jayna Raghwani 2 ; Sylvie M. Koekkoek 1 ; Richard Liang 3 ; Menno D. de Jong 1 ; Oliver Pybus 2 ; Richard Molenkamp 1 ; Janke Schinkel 1 1 AcademicMedCntr,Amsterdam,Netherlands; 2 UnivofOxford,Oxford, UK; 3 BCCntr forExcellence inHIV/AIDS,Vancouver,BC,Canada Sarah E. Kleinstein 1 ; Patrick R. Shea 1 ; Luisa M. Stamm 2 ; Jenny C. Yang 2 ; Philip S. Pang 2 ; Mani Subramanian 2 ; John G. McHutchison 2 ; Mark Sulkowski 3 ; DavidV. Goldstein 1 ; Susanna Naggie 4 Impairment in Cirrhotic Patients TreatedWith DAAs Karin Neukam 1 ; Rafael Granados 2 ; Luis E Morano-Amado 3 ; Manuel Márquez 4 ; FranciscoTéllez 5 ; María José Ríos 6 ; José Hernández-Quero 7 ; Edward R. Cachay 8 ; Juan A. Pineda 9 ; for the Grupo de Estudio de HepatitisVírica, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica: GEHEP-SEIMC; Grupo de Estudio de Hepatitis Vírica, Sociedad Andaluza de Enfermedades Infecciosas y Microbiología Clínica: HEPAVIR; RIS-HEP07 1 ValmeUnivHosp,Seville,Spain; 2 HospUniversitariodeGranCanaria DoctorNegrín,LasPalmas,Spain; 3 HospUniversitarioAlvaroCunqueiro, Vigo,Spain; 4 HospUniversitarioVirgende laVictoria,Málaga,Spain; 5 HospLaLíneade laConcepción (AGSCampodeGibraltar),LaLínea de laConcepción,Spain; 6 HospUniversitarioVirgende laMacarena, Seville,Spain; 7 HospUniversitarioSanCecilio,Granada,Spain; 8 Univof CaliforniaSanDiego,SanDiego,CA,USA; 9 HospUniversitariodeValme, Sevilla,Spain Session P-N11 Poster Abstracts Hall A/B 2:45 PM-4:00 PM HCV: The Virus Is Gone; The Morbidity Not So Much 603 Frequency and Predictors of Liver Function

Poster Listings

WITHDRAWN

596

597 Understanding the Relative Contributions of IDU and HCV on Systemic Immune Activation Martin Markowitz 1 ; Sherry Deren 2 ; Charles Cleland 2 ; Melissa LaMar; Evelyn Silva 3 ; Pedro Batista 2 ; Leslie St. Bernard 1 ; Natanya Gettie 1 ; Haekyung Lee 4 ; Saurabh Mehandru 4 1 AaronDiamondAIDSRsrCntr,NewYork,NY,USA; 2 Cntr forDrugUseand HIVRsr,NewYorkUnivCollofNursing,NewYork,NY,USA; 3 BOOM!Hlth, Bronx,NY,USA; 4 IcahnSchofMedatMountSinai,NewYork,NY,USA 598 Mucosal-Associated Invariant T (MAIT) Cells in HIV/HCV Coinfection

Maddalena Cerrone 1 ; Esther Merlini; Bonnie vanWilgenburg 2 ; Leo Swadling 2 ; CamillaTincati 1 ; Stefania Cannizzo 1 ; Anna De Bona 1 ; Antonella d’Arminio Monforte 3 ; Paul Klenerman 2 ; Giulia Marchetti 4 1 UnivofMilan,Milan, Italy; 2 UnivofOxford,Oxford,UK; 3 Infectious DiseasesClinic,SanPaoloHosp,UnivofMilan,Milan, Italy; 4 Clinicof InfectiousDiseases,UnivofMilan,SanPaoloHosp,Milan, Italy

CROI 2016 113

Made with FlippingBook HTML5